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ABSTRACT
Low concentrations (1-3 µg/ml) of 5-bromodeoxyuridine (BrdU) reversibly suppress pig-
mentation in a highly pigmented clone (B559) of cultured B16 mouse melanoma cells . We
have found that unpigmented cells (clone C3471), derived by long-term culture of B559 cells
in 1 ug of BrdU/ml, were completely amelanotic with no biochemically or cytochemically
detectable tyrosinase activity or ultrastructural evidence of premelanosomes . The process by
which pigmentation is suppressed was studied in B559 cells during a 7-day period of growth
with BrdU (3 µg/ml) . Assays of tyrosinase activity showed that activity was reduced after 1
day and decreased progressively, approaching zero by 7 days . A quantitatively minor part of
this reduction was directly attributable to the appearance of a dialyzable inhibitor of tyro-
sinase activity. Acrylamide gel electrophoresis revealed two bands of activity corresponding
in Rx values to the T, and T2 forms of soluble tyrosinase. Both were progressively reduced
during growth with BrdU but one form (T 1) was consistently affected earlier than the other
(T2). Ultrastructural-cytochemical studies also showed an early effect on the localization of
tyrosinase reaction product . At day 3, reaction product was no longer present in Golgi sac-
cules and Golgi-associated smooth surfaced tubules, but was still seen within premelano-
somes, compound melanosomes, and occasional Golgi-associated vesicles. By 7 days tyrosi-
nase reaction product was usually not demonstrable. The number of premelanosomes was
progressively decreased during growth with BrdU. Premelanosomes became concentrated
in the juxtanuclear region and at day 3 many were contained within abnormally large and
numerous compound melanosomes . Premelanosomes and compound melanosomes were
rarely seen at 7 days, by which time the cultures were nearly amelanotic . The coordinated
suppression of melanogenesis by BrdU may provide a useful model in which to study the
normal regulation of this process.
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Low concentrations of 5-bromodeoxyuridine
(BrdU) have been shown to suppress differentiated
functions preferentially in a variety of cell types
(1-9). Silagi and Bruce (5) reported that treatment
of melanotic melanoma cells (clone B559) with
BrdU altered cellular morphology and suppressed
both pigmentation and tumorigenicity while cell
proliferation continued at a near normal level.
These effects appeared dependent upon incorpora-
tion of the BrdU into cellular DNA as an analogue
of thymidine. The effects upon morphology, pig-
mentation, and tumorigenicity were reversible
upon growth of the cells in normal medium (5,
10). The molecular basis of this reversible effect is
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system in which cellular control of both differ-
entiated function and tumorigenicity may be
studied. We now report more detailed information
on the manner in which treatment with BrdU
results in loss of pigmentation
melanoma cells (clone B559) .
Tyrosinase (EC 1 .10.3.1 ; 0-diphenol :oxygen
oxidoreductase) catalyzes the conversion of tyro-
sine to melanin . The enzyme contains copper
which is required for activity (11, 12) . The abbre-
viated reaction scheme below is based on the










	 > melanin steps
Reactions I and 2 occur enzymatically . The sub-
sequent reactions proceed in the absence of tyro-
sinase but the reaction rates are increased in the




within specialized tyrosinase-containing organelles,
the melanosomes . On the basis of combined cell
fractionation and ultrastructural investigations, the
following scheme was proposed in 1963 for
melanosome formation (15). Tyrosinase is synthe-
sized on ribosomes and then may be transported
through endoplasmic reticulum (ER) to the Golgi
area. Here tyrosinase-containing vesicles are re-
leased. These develop into membrane-limited
particles (premelanosomes) with a distinctive
ordered matrix. The matrix of the premelanosomes
is progressively obscured during melanin synthesis,
resulting in the formation of the fully melanized
mature melanosomes in which tyrosinase activity
is no longer detected. Subsequent investigations
into the role of the Golgi and associated elements
in premelanosome formation have indicated that
new premelanosomes are formed from dilated
cisternae of smooth ER (16, 17) . Novikoff et al.
(16) have suggested that this ER is part of a
specialized system of Golgi-associated smooth ER
(GERL) which is involved in the packaging of
secretory proteins in many cell types (18).
Although tyrosinase activity was cytochemically
demonstrable within GERL and small vesicles
near the Golgi apparatus, melanin was not evident
in these structures (16, 17). Cell fractionation re-
vealed tyrosinase activity associated not only with
the large particulate fraction containing pre-
melanosomes and melanosomes, but also with the
microsomal and soluble fractions (15) . The cellular
mechanisms preventing in vivo melanin synthesis
by extra-melanosomal tyrosinase are not under-
stood. Soluble tyrosinase has been separated by
chromatographic (12) and electrophoretic (19, 20)
means into multiple forms. The origin of these
multiple forms and their relative place in melanin
synthesis in vivo have not been determined. The
present studies were undertaken in order to explore
an experimental system which we believe could be
useful for investigating these and other unresolved
questions concerning normal melanogenesis .
MATERIALS AND METHODS
Cells
The melanoma cell line was derived from the B16
mouse melanoma by Hu (21). Pigmented clones were
produced from this line by Silagi (22) and the highly
melanotic clone, B559, was used in this investigation .
Clone 03471 (5, 10, 23), derived from B559 cells grown
continuously and cloned in medium containing I µg
of BrdU/ml, was also studied . The C3471 cells used
in this study had been exposed to BrdU (I µg/ml) for
a total of approximately 9 mo. Cells were maintained
as monolayer cultures in Eagle's minimal essential
medium with 10% fetal calf serum and antibiotics
as described previously (22). Cells were tested for
Mycoplasma by Hayflick's procedure (24) and found
free from contamination.
B559 and C3471 cells were grown in 32 oz prescrip-
tion bottles, seeded at 2 X 10 5 viable cells/bottle.
Replicate cultures for observation of living cells and
for light and electron microscopy were grown in 35
mm Falcon plastic petri dishes, either directly on the
plastic or on sterile glass cover slips . Cultures were
seeded at 104 viable cells/dish. For time course experi-
ments, cultures of B559 cells were seeded 2 days be-
fore the start of an experiment, then changed to fresh
regular medium or medium containing BrdU (Nu-
tritional Biochemicals Corp ., Cleveland, Ohio) at
the final concentration of 3 pg/ml. For each point in
the time course studies, replicate cultures of cells
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407grown in medium without and with BrdU were com- 25% sucrose were layered directly onto the running
pared (e.g., 3 day controls vs. 3 day treated).
	
gel. Bromphenol blue was mixed with the sample as a
tracking dye and the Rx values were calculated rela-
Enzyme Assays
	
tive to the migration of this dye . The position of bands
containing tyrosinase was revealed by incubation
Cells were harvested with 0.25% trypsin-0.1 % with L-DOPA, according to the method of Burnett et
EDTA (ethylenediaminetetraacetate, disodium salt) al. (20) . Immediately after electrophoresis the gels
in phosphate-buffered saline (PBS) . The cells were were neutralized in 0 .5 M phosphate buffer (pH 6 .6)
washed by centrifugation with PBS and the washed for 30 min, then incubated for I h in 0 .15% L-DOPA
pellet was frozen at -20°C. All subsequent operations in 0.1 M phosphate buffer (pH 6.8) at 37 °C. The in-
were performed at 0-4°C. The frozen pellet was ho- cubation mixture was changed twice during this
mogenized in 0.25 M sucrose with a Dounce ho- period. Gels were fixed in 7.5% acetic acid. Densi-
mogenizer using 50 strokes of a tight pestle . In some tometric tracings at 475 nni were made by scanning
experiments this homogenate was fractionated by fixed gels in a Gilford recording spectrophotometer.
differential centrifugation . The homogenate was
centrifuged at 650 g for 10 min . The pellet was gently
Light Microscopy resuspended in sucrose and recentrifuged . The re-
sulting pellet resuspended in sucrose was termed the Cover slip cultures were fixed at 4°C either over-
"nuclear fraction" . The combined supernatants were night in 4% formaldehyde-1 % calcium chloride (29)
centrifuged at 30,000 g for 30 min. The pellet from or for 10 min-3 h in 3% glutaraldehyde (Ladd Re-
this centrifugation was resuspended in sucrose as the search Industries, Inc., Burlington, Vt.) in 0.2 M
"large particulate" fraction . The 30,000 g supernatant cacodylate buffer (pH 7.4). For demonstration of
was termed the "supernatant fraction" . In other ex- tyrosinase activity the formaldehyde-fixed cells were
periments the supernatant fraction was prepared rinsed in buffer and directly incubated in DOPA-con-
without preliminary fractionation . Usually a sample taining medium (16, 30) while glutaraldehyde-fixed
of the supernatant fraction was dialyzed overnight at cells were rinsed overnight in buffer, containing 7%
4 °C against 0.05 M barbital buffer (pH 8.6). sucrose, before incubation. After incubation, the
Tyrosinase activity was assayed spectrophoto- cover slips were mounted with glycerin jelly on glass
metrically by following the oxidation of L-DOPA to slides.
dopachrome at 475 nm (25) . At this absorption maxi-
mum ofdopachrome, the molar absorbancy coefficient
is 3.7 X 103 (14). The reaction mixture contained
3.8 µ.mol of L-DOPA (Schwarz/Mann Div ., Becton,
Dickinson & Co., Orangeburg, N. Y.), up to 200 µl
of enzyme extract and 0.1 M phosphate buffer, pH
6.8, to a final volume of 2.2 ml. Assays were per-
formed at 30°C in a Gilford recording spectrophotom-
eter (Gilford Instrument Laboratories, Inc ., Oberlin,
Ohio) . Rates were measured during the first few
minutes of the reaction while they were linear. Cor-
rection for DOPA autoxidation was made. One unit
of activity is defined as that amount of enzyme catalyz-
ing the production of 1 µmol of dopachrome per min-
ute and is equal to an increase in absorbance of 1 .6818
A per minute under these conditions . Specific activity
equals units per milligram protein. Protein was esti-
mated by the method of Lowry et al . (26), using Pro-
tein Standard Solution (Armour Pharmaceutical
Co., Chicago, Ill.) of crystalline bovine serum albu-
min standardized by the Kjeldahl method .
Electrophoresis
Soluble tyrosinases were separated by acrylamide
gel electrophoresis. The method of Ornstein (27) and
Davis (28) was modified by the use of more concen-
trated (5 X) reservoir buffer and the omission of
sample and stacking gels. The samples mixed with
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Electron Microscopy
Monolayer cultures of cells were rinsed in physio-
logical saline, fixed for 1 h at 4°C in 3% buffered glu-
taraldehyde, rinsed in buffer, and left overnight at
4°C in buffer containing 7% sucrose. Some cultures
were incubated for cytochemical detection of tyro-
sinase activity as described previously (16, 30) . All of
the cultures were postfixed for 1 h at 4 °C in 1
osmium tetroxide in 0.2 M cacodylate buffer, dehy-
drated through a graded series of alcohols, propylene
oxide, and embedded as a monolayer in Epon 812 .
After polymerization, the petri dish was removed, and
suitable areas were selected for electron microscopy .
Cell pellets were prepared from cultures which had
been changed to calcium-free medium 16-24 h before
trypsinization in order to facilitate removal of the
cells without the use of EDTA. Trypsinized cells were
washed by centrifugation in physiological saline. The
cell pellet was fixed for 1 h in 3%buffered glutaralde-
hyde at 4°C, and processed essentially as described
for the monolayers .
Thin sections were cut from the monolayers and
pellets with a diamond knife on a Porter-Blum MT-1
microtome (Ivan Sorvall, Inc., Newtown, Conn.),
collected on uncoated copper grids, stained lightly
with lead citrate (31), stabilized with carbon (32),RESULTS
Enzyme Assays
Tyrosinase activity in control B 559 cells was
present in various cell fractions separated by
differential centrifugation (Table I). Growth with
3 ig of BrdU/ml for 3 days caused a reduction in
activity of all fractions. In addition the pattern of
distribution of both tyrosinase activity and cell
protein was altered. The BrdU-treated cells showed
an increased proportion of tyrosinase units sedi-
menting with the nuclei at the expense of activity
in the large particulate fraction . Protein distribu-
tion was altered in a similar direction but to a
greater degree. Phase microscopy revealed that the
crude nuclear fraction of both control and BrdU-
TABLE I
Distribution of Tyrosinase Activity in Subcellular Fractions
* (Specific activity of BrdU-treated/specific activity of control) X 100.
$ Replicate cultures of B 559 cells were grown for 3 days in regular medium (Control) or medium contain-
ing 3 .sg of BrdU/ml (BrdU-treated) .
§ Contained melanin granules sedimenting with the nuclei .
11 Total units/total mg protein.
and examined in a Siemens Elmiskop 101 electron
microscope.
A number of tests were made to determine the
specificity of the cytochemical reaction for tyrosinase
activity in both light and electron microscopic prepa-
rations. Some cells were incubated in a substrate-free
medium. Other cells were left overnight at 4°C in
0.2 M cacodylate buffer containing 10-2 M Na
diethyldithiocarbamate (DECA, a copper chelator),
2 mg DOPA/ml and 70 / 0 sucrose, rinsed thoroughly
in buffer, and then incubated with DOPA. In some
experiments, the DECA-treated cells were rinsed in
buffer, left for 1 h in 1 0 / 0 aqueous copper sulfate, and
rinsed again in buffer before incubation .
treated cells contained large numbers of melanin
granules to which we attribute the tyrosinase
activity of this fraction. Visual comparison of the
fractions indicated less melanin in the large par-
ticulate fraction and more melanin in the nuclear
fraction of the treated cells than in these fractions
of the controls.
As tyrosinase activity of all cell fractions was

















FIGURE 1 Changes in tyrosinase specific activity of
the supernatant fraction of B559 cells grown in regular
medium (9) and replicate cultures grown in medium
containing 3 .sg of BrdU/ml (o). Data from one time
course experiment.




U/109 cells % of total
mg/10, cells % of total Specific activity Percent control*
Controls
Nuclear§ 0.62 12 .0 66 .50 17 .3 0 .0093
Large particulate 1 .98 38.4 153 .63 39 .9 0 .0129
Supernatant 2 .55 49.5 165 .25 42 .9 0.0154
Total 5 .15 385 .38 0 .0134"
BrdU-Treated$
Nuclear§ 0 .09 24 .3 152 .69 47 .1 0 .0006 6 .5
Large particulate 0.10 27 .0 46 .19 14.2 0 .0022 17 .1
Supernatant 0 .18 48.6 125 .50 38 .7 0 .0014 9 .1
Total 0 .37 324 .38 0 .0011"supernatant fraction was chosen for time course
studies because of greater ease in studying enzyme
which is primarily in the soluble form .
The results of a time course experiment are
shown in Fig. 1 . In each experiment tyrosinase
specific activity increased during the culture cycle
of untreated B559 cells, while growth with BrdU
(3 Ag/ml) caused a progressive reduction in
activity with time. This decrease in activity was
accompanied by the appearance of a lag period in
the assays of supernatant fraction of BrdU-
treated cells, during which DOPA autoxidation
was inhibited. Representative assays are shown in
Fig. 2. This lag period tended to increase with
time of treatment (Table II) . Dialysis of the











FIGURE 2 Representative assays of tyrosinase activity of the supernatant fraction of untreated B559
cells (control) and B559 cells grown in medium containing 3 jug of BrdU/ml for 3 and 5 days.
TABLE II
Lag Periods in Tyrosinase Assays*
bital buffer (0.05 M, pH 8.6) caused a reduction
in Lowry-positive material and concomitant
modest increase in tyrosinase specific activity.
Dialysis of the supernatant fraction of treated cells
resulted in a similar decrease in Lowry-positive
material but there was also a large increase in de-
tectable units of tyrosinase . The specific activity
was often increased more than 100%. There was
complete loss of the lag period in the assays of
dialyzed material .
Fig. 3 summarizes data from 10 experiments
showing the time course of the effect of BrdU (3
sg/ml) treatment on tyrosinase activity of the
supernatant fraction. A reduction was evident
after only 24 h of culture in the presence of BrdU .
By 2 days the activity of the supernatant fraction
Regular medium
	
Medium with BrdU (3 µg/ml)
* Assays of undialyzed supernatant fraction . After dialysis, the mean lag period was
0.1 min (range 0.0-0.8) with no difference in lag between control and experimental
dialyzed supernatant fractions .
$ Number in parentheses denotes number of extracts assayed .
§ Remaining extracts contained no detectable tyrosinase activity (see Fig. 3).
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Days of Growth Mean lag Range Mean lag Range
min min
1 0.7 - (1)$ 0 .6 - (1)
2 0.6 0.5-0 .9 (3) 3 .2 2 .1-5 .4 (3)
3 0.5 0.0-1 .3 (7) 6 .1 0 .9-13 .1 (7)
5 0.6 0.3,0 .8 (2) 14 .4 - (1)§
7 0 .9 0.5-1 .6 (3) 19.1 9.1,29 .0 (2)§of treated cells was less than 50 % of the control
activity. This reduction continued with longer
periods of growth in medium containing BrdU,
and tyrosinase activity approached zero by 7 days
FIGURE 3 Time course of effect of growth with BrdU
(3 µg/ml) on tyrosinase specific activity . Summary of
10 experiments. Values for the cultures grown with
BrdU are expressed as a percentage of the specific
activity of a replicate control culture grown in regular
medium for the same period . Activities determined on
supernatant fractions before ( •-) and usually also
after dialysis (A---) overnight at 4°C against 0.05 M
Barbital buffer (pH 8.6) . Lines are drawn between the
arithmetic means of multiple experimental points .
of treatment. Variation in the time course of effect
of BrdU in separate experiments should be noted .
For example, the activity of supernatant fractions
of cells treated for 3 days ranged from 7 %
to 28% of control activity. In each individual
experiment, dialysis of the supernatant fraction
resulted in a marked increase in tyrosinase activity
of BrdU-treated cells . However, this increase was
somewhat overshadowed by the variability in
activity of the undialyzed supernatant fractions
from different experiments. In three of five experi-
ments in which cells treated for 7 days with BrdU
were studied, no tyrosinase activity was detectable
in the supernatant fraction . In two of these three
experiments the supernatant fractions were dia-
lyzed and reassayed. No tyrosinase activity was
detectable even after dialysis.
No detectable tyrosinase activity was found in
undialyzed or dialyzed extracts of 03471 cells
grown continuously in medium containing 1 ug of
BrdU/ml . Undialyzed supernatant fraction of
these cells inhibited DOPA autoxidation but this
inhibition was eliminated by dialysis. Mixing ex-
periments with extracts of 0 3471 cells (see Table
III) demonstrated : (a) inhibition of the tyrosinase
activity of untreated B 559 cells, proportional to the
amount of C3471 material present; (b) elimination
of this inhibition by dialysis of 0 3471 extracts; and
(c) the heat stability of inhibitory material in
C3471 extracts. Dialysis against distilled water also
removed inhibitory activity but preliminary at-
tempts to recover inhibitory material for further
study by flash evaporation of the water used for
dialysis were unsuccessful.
TABLE III
Inhibition of Tyrosinase Activity by Supernatant Fraction of C3471 Cells
* C3471 supernatant fraction (volume and treatment as indicated) was added to 25 µl
untreated B559 supernatant fraction immediately before assay .
$ Activity expressed as percent of units detected in untreated B 559 supernatant frac-
tion.
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B559 (25 ml) Ca471 (200 µl)
Mixtures*
(50 11) (100 Al) (200 j.1)
Untreated 100$ 0 75 .4 51 .1 31 .5
Heated 10 min at 100 °C 0 0 46.7 36 .8








FIGURE 4 Effect of growth with BrdU (3 µg/ml) on soluble tyrosinase pattern, as shown by acrylamide
gel electrophoresis. Dialyzed supernatant fraction containing ti 188 jig protein was applied to each
gel. Fig. 4 A, densitometric tracings of gels scanned at 475 nm with a Gilford recording spectropho-
tometer equipped with a linear transport attachment ; migration of bromphenol blue dye marker (BPB).
Fig. 4 B, photograph of same gels. Gel a, control culture grown for 3 days on regular medium . Gel b, repli-









FIGURE 5 Effect of growth with BrdU (3 µg/ml) on
TI and T2 forms of soluble tyrosinase. Dialyzed super-
natant fraction containing approximately 0.0006 U of
tyrosinase activity was applied to each gel . Fig. 5 A,
control B559 cells grown for 3 days on regular medium .
Fig. 5 B, cells of replicate culture grown for 3 days with
BrdU. Fig. 5 C, cells grown for 7 days with BrdU.
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Electrophoresis of the supernatant fraction of
untreated B559 cells revealed the presence of two
soluble forms of the enzyme as well as DOPA-
reactive material unable to penetrate the 7 %
acrylamide gels. The latter may correspond to in-
soluble (small particle-bound) tyrosinase (20) not
sedimented at 30,000 g . The soluble tyrosinase
activity was seen in bands with Rx values of ap-
proximately 0.68 (T1) and 0.57 (T2) . The activity
of T2 appeared greater than that of T1 in untreated
B559 cells.
Treatment with BrdU caused reduction in in-
soluble and soluble activity, without affecting the
Rx values. Fig. 4 depicts the progressive reduction
of T1 and T2 during treatment with 3 ug of
BrdU/ml. In this experiment 7-day treated cells
had no detectable activity by assay, and no bands
of tyrosinase activity were seen upon electro-
phoresis.
The multiple forms of tyrosinase appeared to be
affected unequally by treatment with BrdU. Al-
though the insoluble tyrosinase was difficult to
quantitate, it appeared to be greatly reduced incells treated for 2-3 days . The relative effects on
T1 and T2 are shown in Fig . 5. During the course
of treatment with BrdU, T1 was reduced earlier
than T2 . In experiments in which the supernatant
fraction of 7-day treated cells retained some
activity, that activity was almost exclusively in the
T2 band. It thus appeared that the order of effect
was Tinsol >_ T1 > T2 .
Electrophoresis of supernatant fractions of 0 3471
cells confirmed the absence of tyrosinase activity
in these cells.
Light Microscopy
The untreated melanoma cells grew in a reticu-
lated, piled manner (Fig . 6) . The various control
cultures presented much the same picture except
for some crowding by day 7, and will be described
as a group. Cells were generally spindle-shaped
with melanin granules dispersed throughout the
cytoplasm (Fig. 7). Heavily pigmented cells grow-
ing within densely piled regions contained occa-
sional enlarged melanin granules which were
identified by electron microscopy as compound
melanosomes (Fig. 21, inset). The number of such
cells containing compound melanosomes increased
as the cultures became more crowded. In the con-
trol cultures, a darkening of the melanin granules
was seen after incubation in the DOPA-containing
medium but because of the high degree of pig-
mentation normally present within these cells, it
was not possible to document any increase in pig-
mentation or localization of reaction product in
the Golgi apparatus . The staining reaction as well
as autoxidation of DOPA could be inhibited by
adding DECA (a copper chelator) to the incuba-
tion medium. In order to evaluate whether the
darkening of the melanin granules was due to en-
zyme activity or absorption of oxidized DOPA,
the cultures were first exposed to a solution con-
taining both DECA and DOPA overnight, then
rinsed thoroughly and incubated in DOPA-con-
taining medium without DECA. When this was
done, although autoxidation of DOPA occurred in
the incubation medium, no significant staining of
the cells was observed . The inhibition of tyrosinase
activity by DECA could be partially reversed by
treating the cells with a solution of copper sulfate
before incubation in DOPA-containing medium.
Growth in medium containing 3 sg of BrdU/ml
caused alterations in morphology which were dis-
cernible by 2 days and obvious by 3 days (Fig . 8).
The cells began to disassociate and individual cells
flattened and enlarged . Melanin granules became
concentrated near the nucleus, with a concomi-
tant loss of pigmentation from the cytoplasmic
processes. Additionally, compound melanosomes
were frequently seen in the 3-day treated cells
(Fig. 9) . Incubation of the cells for tyrosinase
activity showed staining of the melanin granules.
With longer periods of growth with BrdU, the cells
became more flattened, exhibited "contact
inhibition", and the juxtanuclear melanin gran-
ules were reduced, with many cells appearing
amelanotic by light microscopy at 7 days (Fig . 10) .
Except for staining of the few melanin granules
present in these cells, there was no cytochemically
demonstrable tyrosinase activity. Continuous
growth in 1-3 pg of BrdU/ml resulted in the pro-
duction of completely amelanotic cell lines (5, 10) .
One of these, clone C3471, is shown in Fig. 11 .
03471 cells grew as a flattened fibroblastic mono-
layer and appeared completely amelanotic . Cells
incubated for tyrosinase activity were completely
negative.
Electron Microscopy
Examination of the control cultures showed that
the melanin granules seen by light microscopy were
premelanosomes and melanosomes in all stages of
development. Because of the difficulty of dis-
tinguishing late premelanosomes from mature
melanosomes we will follow the terminology of
Novikoff et al . (16) in referring to all such granules
as premelanosomes. The control cells were spindle
shaped and contained large numbers of pre-
melanosomes distributed throughout the cyto-
plasm. A well developed Golgi apparatus was
present in control cells (Fig. 12) . Premelanosomes
in the early stages of development were seen fre-
quently near the Golgi apparatus. Occasional
compound melanosomes were found near the
nucleus. Tyrosinase reaction product was localized
in the inner Golgi saccule, Golgi-associated smooth
surfaced tubules and vesicles, premelanosomes and
compound melanosomes (Fig. 16) . Pretreatment
of the cells with DECA prevented the formation of
reaction product (Fig . 17) .
After 3 days of growth with 3 µg of BrdU/ml
the major morphological alteration was the absence
of premelanosomes from the cytoplasmic processes
and their concentration near the nucleus (Fig . 20).
Compared with the controls, the treated cells con-
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an increased concentration of premelanosomes
within the Golgi region (Fig . 13) . Additionally,
there was an increase in the number of large com-
pound melanosomes which appeared to contain
greater numbers of early and intermediate pre-
melanosomes (Fig. 21). Many of the premelan-
osomes contained structural alterations, such as
paracrystalline inclusions (Fig. 22). Examination
of the 3-day treated cells for tyrosinase activity
showed that reaction product was absent from the
Golgi saccules and Golgi-associated smooth sur-
faced tubules (Fig. 18). However, the cells still
showed reaction product in premelanosomes,
compound melanosomes, and in some of the Golgi-
associated vesicles.
Those cells which were exposed to 3 ug of
BrdU/mI for 7 days contained very few premelan-
osomes (Figs. 14 and 19) . Most of those seen were
fully pigmented late premelanosomes, usually
located at the periphery of the Golgi region (Fig.
19) . Small dense bodies were observed which ex-
hibited no tyrosinase activity or recognizable ele-
ments of premelanosomal structure . Based on this
evidence, we did not consider these to be pre-
melanosomes. Except for those few cells which still
retained some pigmentation, compound melan-
osomes were rare . Incubation for tyrosinase
activity revealed no reaction product within most
of the cells examined (Fig . 19). Only the most
pigmented cells showed slight amounts of reaction
product in premelanosomes and small vesicles.
Even in these cells reaction product was usually
not seen in the Golgi saccules or Golgi-associated
smooth surface tubules .
The C3471 cells, grown continuously in the
presence of 1 µg of BrdU/ml, were completely
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amelanotic. A poorly developed Golgi apparatus
was present, but no normal or abnormal pre-
melanosomes were observed within these cells
(Fig. 15) . The dense bodies noted in 7-day treated
cells were not observed in these cultures.
DISCUSSION
We found that the growth of highly pigmented
melanoma cells in the presence of BrdU resulted
in the complete loss of the melanin-synthesizing
system of the cells. The process of suppression of
pigmentation by BrdU appeared to involve four
major effects. These were : (1) progressive reduction
in tyrosinase activity ; (2) suppression of the forma-
tion of premelanosomes; (3) alteration in the cell-
ular distribution of premelanosomes; and (4) loss
of melanin-containing structures from the cells .
Reduction in tyrosinase activity was detected
as early as 24 h after the cultures were changed to
medium containing BrdU (3 ug/ml) . The pro-
gressive reduction with continued treatment was
documented by both biochemical and ultra-
structural-cytochemical studies. Tyrosinase activity
approached zero by 7 days with 3,ug of BrdU/ml
and was undetectable in cultures grown contin-
uously with BrdU (I ug/ml) . At least four possible
mechanisms may be considered to account for the
reduction in tyrosinase activity : (a) an inhibitor of
enzyme activity may be produced ; (b) an altered,
enzymatically inactive form of the tyrosinase
molecule may be produced due to BrdU-induced
mutations; (c) active tyrosinase may be produced
but degraded at an increased rate ; or (d) the syn-
thesis of normal tyrosinase may cease .
The reduction in tyrosinase activity was partially
attributable to dialyzable inhibitory material de-
tected in extracts of BrdU-treated cells. Inhibitors
FIGURES 6 and 7 B559 melanoma cells grown in regular medium. Fig. 6, Living cells. The heavily pig-
mented cells grow in a piled reticulated fashion. X 180. Fig. 7, Formal-calcium fixed cells. Melanin
granules are distributed throughout the cytoplasmic processes (arrow) . X 500.
FIGURES 8 and 9 B559 cells grown for 3 days with 3 µg of BrdU/ml . Fig. 8, Living cells . The cells have
disassociated and melanin granules are concentrated in a juxtanuclear position . X 180, Fig. 9, Formal-
calcium fixed cells. The enlarged melanin granules (arrow) have been identified by electron microscopy
as compound melanosomes (see Fig. 91). X 500.
FIGURE 10 B559 cells grown for 7 days with 3 µg of BrdU/ml. Living cells. Cells are nearly amelanotic.
X 180.
FIGURE 11 C3471 cells derived from long-term culture of B559 cells with 1 ,ug of BrdU/ml. Living cells.
Completely amelanotic cells grow in a fibroblastic manner. X 180.WRATHALL ET AL. Suppression of Pigmentation in Mouse Melanoma Cells
	
415of tyrosinase have previously been reported in ex-
tracts of mammalian skin (33-36), melanomas
(37-40), amelanotic melanoma cells in culture
(22), and amelanotic cells resulting from the
hybridization of pigmented melanoma cells to L
cells (41). Our preliminary characterization of the
inhibitory material in C3471 cells indicates the
presence of heat-stable, dialyzable material cap-
able of inhibiting both DOPA autoxidation and
tyrosinase-catalyzed production of dopachrome .
These results are consistent with the characteristics
of inhibitors prepared from hamster melanoma by
Satoh and Mishima (39) and from an amelanotic
mouse melanoma by Chian and Wilgram (37). In
both of these cases kinetic studies indicated com-
petitive inhibition. The report that homogenates
of a variety of mammalian organs are capable of
inhibiting in vitro tyrosinase activity (42) indicates
the need for caution in ascribing specific regulatory
functions to all detectable inhibitors. In our ex-
periments in which an inhibitor of tyrosinase
activity was detected in cells at a time when pig-
ment production was being suppressed, it seems
reasonable to postulate a correlation . The produc-
tion of inhibitory material may facilitate the sup-
pression of melanogenesis and/or the maintenance
of the amelanotic state. However, our data on
dialyzed supernatant fraction indicated that the
direct effect of the inhibitory material on tyro-
sinase activity was quantitatively minor compared
to the total decrease of activity in BrdU/treated
cultures.
If most of the decrease of tyrosinase activity
cannot be accounted for by the presence of inhibi-
tory material, then the remaining three postulated
mechanisms must be considered . The reversible
nature of BrdU suppression of pigmentation (5)
rules out the possibility that inactive tyrosinase
resulted from BrdU-induced mutations. A trans-
itory increase in degradation of tyrosinase may
occur within the large numbers of compound
melanosomes noted in cells during the early stages
of treatment with BrdU . However, increased
degradation seems an unlikely mechanism fox the
production of long-term amelanotic tyrosinase-
negative cell lines by BrdU .
We think the most reasonable hypothesis to
account for the eventual absence of tyrosinase
activity in cultures grown in the presence of BrdU
is that it causes the synthesis of tyrosinase to cease .
Stellwagen and Tomkins (8) demonstrated that
growth with BrdU (3 )ug/ml) for a 30 h period
caused a reduction in tyrosine aminotransferase
activity of hepatoma cells by reducing the rate of
synthesis of this enzyme. BrdU may act similarly
in melanoma cells to decrease and eventually stop
synthesis of the enzyme tyrosinase .
An additional aspect of the reduction of tyro-
sinase activity during BrdU treatment is the prefer-
ential effect on the T 1 form of soluble tyrosinase .
We detected two forms of soluble tyrosinase in
preparations of untreated melanoma cells with Rx
values (0.68 and 0.57) similar to the Ti and T2
forms reported in studies of normal melanocytes
from a variety of mammals (43) and both mouse
(20) and human (44) melanomas . We found no
evidence of a third form (T3) which has been de-
tected in preparations of hair bulk melanocytes of
some mammals (43) but not in either mouse (20)
or human (44) melanomas .
The origin of these multiple soluble forms of
tyrosinase is obscure . The C locus in the mouse
apparently contains the structural gene for tyro-
sinase (43, 45) and the multiple soluble forms
probably result from secondary modifications of
the product of the C locus (43) . Variations have
been reported in the relative activity and Rx
values of the multiple forms of tyrosinase in ex-
FIGURE 12 B559 cell grown in regular medium. A portion of the Golgi apparatus is shown . Premelano-
somes (arrows) in various stages of development are associated with it. X 24,000.
FIGURE 13 B559 cell grown for 3 days with 3 µg of BrdU/ml . A portion of the Golgi apparatus with
associated premelanosomes (arrows) is shown . Increased numbers of premelanosomes in the early stages
of development (arrowheads) are present in this area . X 25,000.
FIGURE 14 B559 cell grown for 7 days with 3 sg of BrdU/ml . No premelanosomes are associated with
the Golgi apparatus. (N, nucleus). X 33,600.
FIGURE 15 C3471 cell grown continuously with 1 µg of BrdU/ml. No premelanosomes are associated
with the Golgi apparatus. (C, centrioles). X 20,000.
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417tracts of melanocytes from different mammals (43)
and different genotypes of the mouse (19, 43) .
However, the consistent presence and Rx value of
the T, form has been noted in all preparations of
melanotic melanocytes (43) . T, seems to be a key
form and could be the original, or only slightly
modified, product of the C locus which is subject
to secondary modification.
Tyrosinase has been solubilized from both
melanosomal (46) and smooth membrane (47)
fractions of Harding-Passey mouse melanoma .
Only a single form of tyrosinase, corresponding to
the T, soluble form, was revealed by acrylamide
electrophoresis of the purified preparations, al-
though both T, and T2 are present in the soluble
fraction of this melanoma (20, 46). The absence of
detectable T2 in the melanosomal preparation
raises doubt that this form of tyrosinase is active
in melanin synthesis in vivo. The apparent absence
of T2 in the smooth membrane fraction suggests to
us that it is the T, form of tyrosinase which has
been cytochemically demonstrated in the GERL
(16). This suggestion is strengthened by our finding
that the early reduction in the T, form of soluble
tyrosinase during suppression of pigmentation by
BrdU was correlated with the early loss of tyro-
sinase activity from the Golgi saccules and Golgi-
associated smooth surfaced tubules.
On the basis of our finding that T, decreased
before T2 during BrdU-induced suppression of
melanogenesis, and the evidence of other authors
described above, we suggest that T, may be a pre-
cursor form from which T2 (and T3 where present)
is produced by secondary modification. As the
molecular weight of the T2 (and T3) form is lower
than that of T, (43, 48), this modification may in-
volve the removal of a portion of the T, molecule.
T2 could be a degraded form of tyrosinase which is
not destined to be incorporated into, or has been
released from, melanosomes. If T2 is actually
418
derived from the T, form, then the onset of melano-
genesis in previously amelanotic cells may show
evidence of T, before the appearance of the T2
form. We are studying cultures reversing after
BrdU treatment to determine whether this is the
case.
The reduction of tyrosinase activity by BrdU
was coordinated with a suppression of premelan-
osome formation. Extensive formation of pre-
melanosomes in control cells was indicated by the
presence of large numbers of premelanosomes in all
stages of development and the detection of tyro-
sinase reaction product in Golgi saccules, Golgi-
associated vesicles, and smooth surfaced tubules .
These tubules probably correspond to the GERL
from which premelanosomes are considered to
arise in B16 melanoma (16) . Tyrosinase reaction
product was not seen in the Golgi saccules of B16
melanoma (16), in contrast to our findings in
Bs59 cells. This may indicate physiological differ-
ences between these cultured cells and the solid
tumor from which they were originally derived .
The normal formation of premelanosomes was
suppressed by culture of melanoma cells in medium
containing BrdU. The suppression of pigmentation
by BrdU did not result in an albino phenocopy .
In albino (c/c) mice tyrosinase activity is absent
but amelanotic melanosomes are produced (49) .
We have found no evidence of premelanosomes,
normal or altered, in amelanotic cells (clone 0 3471)
produced by long-term culture in the presence of
I µg of BrdU/ml. Reduced premelanosome forma-
tion was indicated in cells treated for 3 days with
3 µg of BrdU/ml by the general absence of tyro-
sinase reaction product in the Golgi saccules and
Golgi-associated smooth surfaced tubules of these
cells . Cells treated for 7 days did not show tyro-
sinase reaction product in the Golgi saccules,
Golgi-associated smooth surfaced tubules, or ves-
icles, and the absence of early forms of premelan-
FIGURES 16-19 Thin sections of cells incubated for tyrosinase activity . Fig. 16, B559 cell grown in
regular medium. Tyrosinase reaction product is localized in the inner Golgi saccule (arrowhead), Golgi-
associated smooth surfaced tubules (long arrows) and vesicles (short arrows), and in premelanosomes
(P) . X 20,000. Fig. 17, B559 cell grown in regular medium . Treated before incubation with a tyrosinase
inhibitor, DECA. The absence of reaction product in intermediate premelanosomes (arrows) and asso-
ciated structures indicates the specificity of the tyrosinase reaction . X 20,000. Fig. 18, B559 cell grown
for 3 days with 3 jug of BrdU/ml. Tyrosinase reaction product is localized primarily in the compound
melanosome (CSI). Many premelanosomes (arrows) contain no reaction product. X 19,000. Fig. 19,
B559 cell grown for 7 days with 3 µg of BrdU/ml . No reaction product is present in the Golgi sac-
cules or any associated structure . P, premelanosome . X 20,000.
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419FIGURE 20 B559 cell grown for 3 days with 3 ug of BrdU/ml. Individual premelanosomes (arrows) are
concentrated near the nucleus (N). X 3,200.
osomes in these cells indicated that new formation
had ceased. It thus appears that treatment with
BrdU causes a progressive reduction of premelan-
osome formation.
The most dramatic morphological alteration ob-
served during culture of melanoma cells in medium
containing BrdU was the juxtanuclear concentra-
tion of pigment first seen in cells at 2 days . Electron
microscopic studies of 3-day treated cultures
showed that this juxtanuclear pigment consisted of
a high concentration of individual premelanosomes
and compound melanosomes and confirmed the
absence of premelanosomes in thecytoplasmic proc-
esses of these cells . We have no direct evidence
for the mechanism(s) which cause this effect but
our ultrastructural studies indicated decreased
numbers of premelanosomes in cells treated for 3
days; thus some loss does appear to occur during
production of this altered pigment distribution.
However, the concentration of premelanosomes
in the juxtanuclear region also appeared to be
greater than in control cells, inferring that either
absence of outward movement or actual inward
movement may also be involved .
The production of amelanotic cells by BrdU
requires the loss of melanin-containing structures
as well as suppression of new melanin production .
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We found some decrease in number of premelan-
osomes during the first 3 days of treatment with
BrdU, and a marked reduction between the 3rd
and 7th day of culture in medium containing 3 gg
of BrdU/ml. The abnormal number and composi-
tion of compound melanosomes in cells treated for
3 days may facilitate this loss . The formation of
compound melanosomes has been considered as a
possible catabolic process, with these structures
serving as autophagic vacuoles (16). The com-
pound melanosomes of 3-day treated cells contain
unusually high numbers of premelanosomes in
early stages of development; this may represent
an altered manifestation of a process which occurs
normally in untreated melanoma cells . We have
not, however, obtained evidence that pigment is
lost by actual degradation in situ within compound
melanosomes. If this occurred, residual bodies
should have been seen in 7-day treated cells. Cell
division would per se cause a dilution of melanin,
but we believe that the extent of loss indicates
there is also elimination of compound melanosomes
and individual premelanosomes from cells grown
with BrdU.
The four major effects of BrdU on pigmentation
in melanoma cells which we have discussed
separately occurred together in the cells. The evi-FIGURE 21 B559 cell grown for 3 days with 3 µg of BrdU/ml . The large, membrane-limited, compound
melanosome (arrow) contains primarily premelanosomes in the early stages of development . X 14,400.
Inset, A compound melanosome from a control cell is composed of late, N-,ell pigmented premelanosomes .
x 10,000.
FIGURE 22 B559 cell grown for 3 days with 3 µg of BrdU/ml . A paracrystalline inclusion is present in
one premelanosome (arrowhead) . A small compound melanosome delimited by a unit membrane is also
shown (arrow). X 34,400.
dence of coordinated reduction of tyrosinase tural as well as enzymic function within melan-
activity and suppression of premelanosome forma- osomes (49) . Melanosomal structure appears to be
tion is particularly significant. Tyrosinase, the under complex genetic control, as fine structural
product of the C locus, is thought to have a struc- alterations in melanosomal morphology have also
WRATHALL ET AL . Suppression of Pigmentation in Mouse Melanoma Cells
	
421been described for mutants at the B and P loci
(49). The complex genetics indicates that a number
of primary gene products are probably needed for
the normal production of functional melanosomes .
BrdU appears, directly or indirectly, to affect all
of these products . We believe that the coordinated
effects of treatment with BrdU on the melanin-
synthesizing apparatus of these melanoma cells
may provide a useful experimental system in which
the normal regulation of melanogenesis can be
probed.
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